Latest Breaking News On - Zonghai li - Page 1 : comparemela.com

CARsgen Announced 2023 Annual Results

/PRNewswire/ March 27, 2024, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the.

London
City-of
United-kingdom
China
Huadong
Guangdong
Canada
United-states
Shanghai
American
Zonghai-li
Carsgen-therapeutics-holdings-limited-stock-code

CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

Shanghai
China
Renji
Henan
Bo-zhai
Guangxi
Zonghai-li
Prnewswire-carsgen-therapeutics-holdings-limited-stock-code
Cancer-communications
Shanghai-jiao-tong-university-school-of-medicine
Carsgen-therapeutics-holdings
Department-of-interventional-oncology-renji-hospital

CARsgen and Moderna to test cancer combo - BioProcess Insider

CARsgen and Moderna to test cancer combo - BioProcess Insider
bioprocessintl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioprocessintl.com Daily Mail and Mail on Sunday newspapers.

United-states
China
America
Zonghai-li
Lin-guey
Research-ventures
External-research-ventures

CARsgen Announced 2023 Interim Results

CARsgen Announced 2023 Interim Results
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Shanghai
China
Jinshan
Sichuan
Xuhui
Huadong
Guangdong
Japan
Research-triangle-park
North-carolina

Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T

The companies will evaluate Moderna’s investigational Claudin18.2 mRNA cancer vaccine in combination with CARsgen’s Claudin18.2 CAR T cell candidate.

Cambridge
Cambridgeshire
United-kingdom
China
Chinese
Lin-guey
Carsgen-claudin
Zonghai-li
Regenerative-medicine-advanced-therapy
Orphan-drug
Resume